PRO: The Food and Drug Administration Black Box Warning on Droperidol Is Not Justified
Authors:
- Ashraf S. HabibAHAshraf S. Habib
- Tong J. GanTGTong J. Gan
- 1 May 2008
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 106 (5) , 1414-1417
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- The use of droperidol before and after the Food and Drug Administration black box warning: a survey of the members of the Society of Ambulatory AnesthesiaJournal of Clinical Anesthesia, 2008
- Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgeryEuropean Journal of Anaesthesiology, 2007
- QT Interval MeasurementAnesthesiology, 2006
- Effect of Low-dose Droperidol on the QT Interval during and after General AnesthesiaAnesthesiology, 2005
- Is Low-dose Haloperidol a Useful Antiemetic?Anesthesiology, 2004
- The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trialsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2004
- Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: a case reportCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2003
- Sevoflurane and Torsade de PointesAnesthesia & Analgesia, 1998
- Torsade de Pointes Ventricular Tachycardia During, but Not Necessarily Caused by, Sevoflurane AnesthesiaAnesthesia & Analgesia, 1998
- Rate-corrected QT interval: Techniques and limitationsThe American Journal of Cardiology, 1993